Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7319000
Compositions and methods for eliciting immune or anti-infective responses
granted -
US 7314911
Prostate hyperplasia therapy
granted -
US 7312202
Rationally designed and chemically synthesized promoter for genetic vaccine and gene therapy
granted -
US 7309792
Dimeric small molecule potentiators of apoptosis
granted -
US 7309692
Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
granted -
US 7306804
HIV-specific T-cell induction
granted -
US 7303887
Mule: Mcl-1 ubiquitination ligase E3
granted -
US 7291348
Compositions and methods for biodegradable microspheres as carriers of bioactive substances
granted -
US 7288646
USPA2 nucleic acid of Moraxella catarrhalis
granted -
US 7288369
Replication competent hepatitis C virus and methods of use
granted -
US 7285556
Thienopyrimidine-based inhibitors of the src family
granted -
US 7271161
Platinum complexes as antitumor agents in combination with biochemical modulation
granted -
US 7271148
Inhibition of cellular proteases
granted -
US 7261875
Dendritic poly (amino acid) carriers and methods of use
granted -
US 7256047
Measurement of gluconeogenesis and intermediary metabolism using stable isotopes
granted -
US 7252989
Adenovirus supervector system
granted -
US 7247303
Selected antibody CDRs for binding to aminophospholipids
granted -
US 7247316
Compositions and methods for treating lymphoma
granted -
US 7244760
Methods for preparation and use of psorospermin analogs
granted -
US 7244617
Diminishing viral gene expression by promoter replacement
granted -
US 7244450
Compositions and methods for treating lymphoma
granted -
US 7238366
Submicron liposome suspensions obtained from preliposome lyophilizates
granted -
US 7229604
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
granted -
US 7223388
Modified reoviral therapy
granted